Clinical Research Fellow Full-time

Clinical Research Fellow

We are seeking a Clinical Research Fellow to support the clinical delivery of the REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with stable relapsing-remitting multiple sclerosis (RRMS).

You will play a key role in patient recruitment, clinical assessments, and data collection, working closely with colleagues at UCLH and the MRC Clinical Trials Unit. Responsibilities will also include coordinating blood sample analysis, contributing to data interpretation, and supporting public and patient engagement activities.

This academic post offers opportunities to participate in additional research projects and the clinical care of people living with MS.

An honorary contract will be sought from UCLH NHS Foundation Trust, and other Trusts where the postholder may provide input, for which a DBS check will be required.

The post is available from 01 November 2026 and funded by the National Institute for Health and Care Research – Efficacy and Mechanism Evaluation (NIHR EME) for two years in the first instance.

If you need reasonable adjustments or a more accessible format to apply for this job online, or have any queries regarding the application process, please contact the Institute of Neurology HR Team (ion.hradmin@ucl.ac.uk).

Informal enquiries regarding the role can be addressed to Professor Olga Ciccarelli (email: o.ciccarelli@ucl.ac.uk).

A full job description and person specification for this role can be accessed below. To apply, please upload a current CV, complete the online application form, and use the supporting statement section or upload a cover letter to outline how you meet the essential and desirable criteria for the role. Please do not upload any additional attachments as these will not be considered by the selection panel.

Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more about the benefits offered.